Hill Incorporated Releases Q2 FY 2024 Results
March 1, 2024
Ryan Allway March 1st, 2024 News, Top News, Top Story We Continued toExpand the DehydraTECH Licensee Eco-System, As Leading Multi-StateOperator MariMed Inc. Launched New DehydraTECH-Powered Products inQ2 DehydraTECHLicensee 1906 Launched an Exciting New Direct-To-Consumer ProductLine, Produced Using DehydraTECH, Across A Majority of US StatesDuring Q2, Adding to Their Existing... Read more
Hill Incorporated Announces New DehydraTECH Licensing Agreement with Leading Multi-State Operator MariMed Inc.
November 16, 2023
Ryan Allway November 16th, 2023 News, Top News, Top Story In a multi-year deal, MariMed licenses DehydraTECH to power new and improved versions of products under their top-selling cannabis edibles brands ‘Vibations’ hydrating drink mix and ‘K Fusion’ chewable tablets, with additional brands and new products expected to follow.... Read more
Hill Incorporated Releases FY2023 Financial Results
October 24, 2023
Note 1: The Company has reduced its year-over-year trade payables by 66% while maintaining consistent cash reserves. Note 2: As of Oct 23, 2023, the Company has collected over 80% of its receivables that were outstanding as at June 30, 2023. The remaining 20% is expected to be collected by Nov 30,... Read more
Ryan Allway March 1st, 2023 News, Top News Toronto, ON – TheNewswire – March 1, 2023 – Hill Street Beverage Company Inc. (TSXV:HILL) (OTC:HSEEF) (“Hill Street” or the “Company”), a progressive bioscience implementation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally, is pleased to announce the... Read more
Lexaria’s Newest DehydraTECH(TM) 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever
CBD May 20, 2021
Ryan Allway May 20th, 2021 New formulation delivers up to 2,708% more CBD into bloodstream* Human clinical hypertension study HYPER-H21-1 also progressing KELOWNA, BC / ACCESSWIRE / May 20, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased... Read more
